US 2010/0247577 A1Published application

Tr1 cells, mesenchymal stem cells and uses thereof

AssigneeTxcell

InventorsArnaud Foussat, Nathalie Belmonte

Life of this patent

Estimating the term…

Abstract

The present invention relates to compositions comprising Tr1 cells and mesenchymal stem cells and methods for treating an autoimmune disease, an allergic disease or an inflammatory disease.

Claims19

Dependent claims

Composition comprising Tr1 cells and mesenchymal stem cells.

Dependencies are inferred from the claim text.

Facts

Application: 12/682,061Filed 17 Oct 2008
Priority: 17 Oct 2007
Published: 30 Sep 2010
Term ends: Not estimatedThe source records don’t support an estimate.

Classification27 codes

C12N 5/0636
Cells from the blood or the immune system: t lymphocytes
A61K 40/11
Characterised by the cell type used: t-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer…
A61K 40/22
Characterised by the effect or the function of the cells: immunosuppressive or immunotolerising
A61K 40/416
Vertebrate antigens: antigens related to auto-immune diseases; Preparations to induce self-tolerance

Family

Application60/980,541Us provisional application · filed 17 Oct 2007
US 2010/0247577 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results